Publications by authors named "Polterauer Stephan"

Claim this Profile
S
Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer - exploratory analysis from the CCTG CX.5/SHAPE trial.
Sven Mahner, Fabian Trillsch, Janice S Kwon, Sarah E Ferguson, Paul Bessette, Stephan Polterauer

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
Melina Danisch, Magdalena Postl, Thomas Bartl, Christoph Grimm, Alina Sturdza, Stephan Polterauer

J Pers Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of low-risk endometrial cancer with isolated tumor cells in the sentinel lymph nodes: a prospective, multi-center, single-arm, observational study (ENDO-ITC study).
Luigi A De Vitis, Giorgio Bogani, Francesco Raspagliesi, Octavio Arencibia Sanchez, Beatriz Navarro, Stephan Polterauer, Stephanie Gill

Int J Gynecol Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-based radiomic prognostic vector (RPV) predicts survival and stromal histology in high-grade serous ovarian cancer: an external validation study.
Georg J Wengert, Haonan Lu, Eric O Aboagye, Georg Langs, Nina Poetsch, Stephan Polterauer

Eur Radiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High CD36 expression in the tumor microenvironmental vasculature correlates with unfavorable overall survival in high grade serous ovarian cancer.
Christina T Grech, Stefanie Aust, Gerda Hofstetter, Esther Uhl, Lorenz Hinterleitner, Stephan Polterauer

Sci Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.
Valentina Glueck, Christoph Grimm, Magdalena Postl, Christian Brueffer, Nuria Segui, Stephan Polterauer

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium.
Gesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, Toon Van Gorp, Eva Welsch, Stephan Polterauer

Int J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?
Arina Onoprienko, Thomas Bartl, Christoph Grimm, Nicole Concin, Stephan Polterauer

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Value of the Fibrinogen-Albumin-Ratio Index on Surgical Outcomes in Patients with Advanced High-Grade Serous Ovarian Cancer.
Magdalena Postl, Melina Danisch, Fridolin Schrott, Paul Kofler, Patrik Petrov, Stephan Polterauer

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of transcription factor in patients with endometrial cancer of no specific molecular profile (NSMP) subtype.
Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer

Int J Gynecol Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience.
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Stephan Polterauer

J Pers Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Stephan Polterauer

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma.
Rasiah Bharathan, Stephan Polterauer, Martha C Lopez-Sanclemente, Hanna Trukhan, Andrei Pletnev

J Pers Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
Richard Schwameis, Francesco Fanfani, Christoph Ebner, Naomi Zimmermann, Inge Peters, Stephan Polterauer

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, Stephan Polterauer

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report.
Postl Magdalena, Bartl Thomas, Poetsch Nina, Reinthaller Alexander, Andreas Martin, Polterauer Stephan

Gynecol Oncol Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Krukenberg Progression of Gastric Carcinoma in Pregnancy: Is Early Diagnosis Possible? Case Report and Review of the Literature.
Fanny Eckel, Greta Carlin, Stefanie Mayer, Stephan Polterauer, Kinga Chalubinski

J Clin Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Ignacio Zapardiel, Myriam Gracia Segovia, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Stephan Polterauer

Int J Gynecol Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial.
Renaud Sabatier, Frédérique Rousseau, Florence Joly, Claire Cropet, Coline Montégut, Stephan Polterauer

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022).
Clemens Tempfer, Lars-Christian Horn, Sven Ackermann, Ralf Dittrich, Jens Einenkel, Stephan Polterauer

Geburtshilfe Frauenheilkd· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival.
Myriam Gracia, Yusuf Yildirim, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Stephan Polterauer

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer.
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Stephan Polterauer

J Pers Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients.
Christina T Grech, Dietmar Pils, Stefanie Aust, Christoph Grimm, Stephan Polterauer

J Pers Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
Christian Marth, Miguel Henriques Abreu, Klaus Kaae Andersen, Karoliina M Aro, Maria de Lurdes Batarda, Stephan Polterauer

Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters.
Elisabeth Reiser, Dietmar Pils, Christoph Grimm, Ines Hoffmann, Stephan Polterauer

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis